Evidence map›Paper›PMID 37292990›Full record

ArticlebioRxiv : the preprint server for biology2023

A bioinformatics tool for identifying intratumoral microbes from the ORIEN dataset.

Cankun Wang, Anjun Ma, Megan E McNutt, Rebecca Hoyd, Caroline E Wheeler, Lary A Robinson, Carlos H F Chan, Yousef Zakharia, Rebecca D Dodd, Cornelia M Ulrich and 19 more

Registry-linked trialAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02328677 (ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02328677 recruitingnot on this map

ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis

TypeobservationalSponsorUniversity of UtahRan2007 to 2030Enrolled5,000ConditionsColorectal Cancer
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Cankun WangDepartment of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH, USA.
Anjun MaDepartment of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH, USA.
Megan E McNuttDepartment of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH, USA.
Rebecca HoydDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Caroline E WheelerDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Lary A RobinsonDepartment of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Carlos H F ChanUniversity of Iowa, Holden Comprehensive Cancer Center, Iowa City, IA, USA.
Yousef ZakhariaDivision of Oncology, Hematology and Blood & Marrow Transplantation, University of Iowa, Holden Comprehensive Cancer Center, Iowa City, IA, USA.
Rebecca D DoddDepartment of Internal Medicine, University of Iowa, Iowa City, IA, USA.
Cornelia M UlrichDepartment of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Sheetal HardikarDepartment of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Michelle L ChurchmanClinical & Life Sciences, M2GEN, Tampa, FL, USA.
Ahmad A TarhiniDepartments of Cutaneous Oncology and Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Eric A SingerDepartment of Urologic Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Alexandra P IkeguchiDepartment of Hematology/Oncology, Stephenson Cancer Center of University of Oklahoma, Oklahoma City, OK, USA.
Martin D McCarterDepartment of Surgery, University of Colorado School of Medicine, Aurora, CO, USA.
Nicholas DenkoDepartment of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Gabriel TinocoDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Marium HusainDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Ning JinDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Afaf E G OsmanDepartment of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
Islam EljilanyClinical Science Lab -- Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Aik Choon TanDepartments of Oncological Science and Biomedical Informatics, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Samuel S ColemanDepartments of Oncological Science and Biomedical Informatics, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Louis DenkoPelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus; OH, USA.
Gregory RiedlingerDepartment of Precision Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Bryan P SchneiderIndiana University Simon Comprehensive Cancer Center, Indianapolis, IN, USA.
Daniel SpakowiczPelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus; OH, USA.
Qin MaDepartment of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH, USA.

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI KATHARINE S ULLMAN · 1986 to 2026
$72.6M
Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
The Ohio State University Center for Clinical and Translational Science (UL1)UL1TR000090 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2012 to 2013
$7.9M
Autism Speaks AS1695NCATS NIH HHS UL1 TR000090NCI NIH HHS P30 CA016058NCI NIH HHS P30 CA042014NCI NIH HHS P30 CA086862
6 · The paper itself

Abstract

Evidence supports significant interactions among microbes, immune cells, and tumor cells in at least 10-20% of human cancers, emphasizing the importance of further investigating these complex relationships. However, the implications and significance of tumor-related microbes remain largely unknown. Studies have demonstrated the critical roles of host microbes in cancer prevention and treatment responses. Understanding interactions between host microbes and cancer can drive cancer diagnosis and microbial therapeutics (bugs as drugs). Computational identification of cancer-specific microbes and their associations is still challenging due to the high dimensionality and high sparsity of intratumoral microbiome data, which requires large datasets containing sufficient event observations to identify relationships, and the interactions within microbial communities, the heterogeneity in microbial composition, and other confounding effects that can lead to spurious associations. To solve these issues, we present a bioinformatics tool, MEGA, to identify the microbes most strongly associated with 12 cancer types. We demonstrate its utility on a dataset from a consortium of 9 cancer centers in the Oncology Research Information Exchange Network (ORIEN). This package has 3 unique features: species-sample relations are represented in a heterogeneous graph and learned by a graph attention network; it incorporates metabolic and phylogenetic information to reflect intricate relationships within microbial communities; and it provides multiple functionalities for association interpretations and visualizations. We analyzed 2704 tumor RNA-seq samples and MEGA interpreted the tissue-resident microbial signatures of each of 12 cancer types. MEGA can effectively identify cancer-associated microbial signatures and refine their interactions with tumors.

Indexed as

cancerdeep learningmicrobiometumor microbiome

Identifiers

PMID37292990
PMCPMC10245834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.